Subdermal Contraceptive Implants Market Size, Share & Trends Analysis Report By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2019 - 2026
This report can be delivered to the clients within 12-14 business days
The global subdermal contraceptive implants market size is expected to reach USD 969.2 million by 2026, according to a new report by Grand View Research, Inc., registering a 3.2% CAGR over the forecast period. Introduction of several modern contraceptives in the market, growing awareness about various birth control methods, and high per capita income are some of the key factors driving the market for subdermal implants for birth control.
According to the Guttmacher Institute, in 2014, approximately 20 million women needed publicly funded contraceptive services. According to CDC, in 2017, nearly 46.9 million women in the U.S. were using at least one method of contraception. Subdermal implant is a long-term birth control option for women. Subdermal implants for contraception are in the form of polymer capsules or rods placed under the skin. The progestational hormone is released at a slow and stable rate, providing effective contraception for 1-5 years.
Publicly funded family planning services help women avoid or plan pregnancies. In 2012, the South Carolina Department of Health and Human Services (SCDHHS) revised the cost associated with Medicaid payment policy for immediate postpartum insertion of Long-Acting Reversible Contraception (LARC). Under this new reimbursement policy, providers are allowed to bill for the insertion procedure and the cost of an IUD or an implant, in addition to the Diagnosis Related Group (DRG) by using J-codes with a family planning modifier.
Implants are the most widely used contraceptive methods by women in sub-Saharan Africa owing to public-private partnerships between manufacturers, donors, governments, and international agencies, which helps lower commodity cost and increase product availability. Contraceptive usage has increased in South Africa, Malawi, and Rwanda. According to PLOS.org, in Malawi, the use of the Long-acting Reversible Contraception (LARC) method reached 10.21% in urban areas in 2016 and 9.66% in rural areas. In 2012, an initiative called Family Planning 2020 (FP2020) was launched to give 120 million women access to modern contraceptive methods by 2020.
Further key findings from the report suggest:
The global subdermal contraceptive implants market size is expected to reach USD 969.2 million by 2026, according to a new report by Grand View Research, Inc., registering a 3.2% CAGR over the forecast period. Introduction of several modern contraceptives in the market, growing awareness about various birth control methods, and high per capita income are some of the key factors driving the market for subdermal implants for birth control.
According to the Guttmacher Institute, in 2014, approximately 20 million women needed publicly funded contraceptive services. According to CDC, in 2017, nearly 46.9 million women in the U.S. were using at least one method of contraception. Subdermal implant is a long-term birth control option for women. Subdermal implants for contraception are in the form of polymer capsules or rods placed under the skin. The progestational hormone is released at a slow and stable rate, providing effective contraception for 1-5 years.
Publicly funded family planning services help women avoid or plan pregnancies. In 2012, the South Carolina Department of Health and Human Services (SCDHHS) revised the cost associated with Medicaid payment policy for immediate postpartum insertion of Long-Acting Reversible Contraception (LARC). Under this new reimbursement policy, providers are allowed to bill for the insertion procedure and the cost of an IUD or an implant, in addition to the Diagnosis Related Group (DRG) by using J-codes with a family planning modifier.
Implants are the most widely used contraceptive methods by women in sub-Saharan Africa owing to public-private partnerships between manufacturers, donors, governments, and international agencies, which helps lower commodity cost and increase product availability. Contraceptive usage has increased in South Africa, Malawi, and Rwanda. According to PLOS.org, in Malawi, the use of the Long-acting Reversible Contraception (LARC) method reached 10.21% in urban areas in 2016 and 9.66% in rural areas. In 2012, an initiative called Family Planning 2020 (FP2020) was launched to give 120 million women access to modern contraceptive methods by 2020.
Further key findings from the report suggest:
- North America held the maximum share in the market for subdermal implants for contraception in 2018. This can be attributed to growing number of unwanted pregnancies, increased government initiatives in favor of contraception, and rising unmet needs
- Strong economic growth in countries such as China, India, and Singapore, increasing awareness about contraceptives and STIs, and rising disposable income are expected to boost the Asia Pacific market in the coming years
- Rapid population growth is a major concern in sub-Saharan African countries; the region’s population growth is projected to account for more than half of the global population growth by 2050. This could have a positive impact on the uptake of subdermal implants for birth control
- Some of the key subdermal contraceptive implants market players are Shanghai Dahua Pharmaceutical Co., Ltd.; Merck & Co., Inc.; and Bayer AG. In February 2018, Shanghai Dahua Pharmaceutical Co., Ltd. and DKT International entered into an agreement to market Levoplant at a reduced price of USD 6.90 per unit in 69 countries.
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation & Scope
1.1.1 Regional Scope
1.1.2 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.2 Variable analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective -
1.10.2 Objective -
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Region
2.3 Competitive Insights
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage outlook
3.1.1 Parent market outlook
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Rise in the number of initiatives to promote contraceptive methods
3.3.1.2 Increasing number of unwanted pregnancies
3.3.2 Market restraint analysis
3.3.2.1 Rapidly aging population and rising prevalence of infertility
3.3.2.2 Lack of awareness and adverse effects of contraceptive implants
3.4 Business Environment Analysis Tools
3.4.1 Porter’s five forces analysis
3.4.2 PESTEL analysis
3.5 Major Deals & Strategic Alliances Analysis
3.6 Pipeline Analysis
CHAPTER 4 CONTRACEPTIVE IMPLANTS MARKET: REGIONAL ANALYSIS
4.1 Contraceptive Implants Regional Market Share Analysis, 2018 & 2026
4.2 Contraceptive Implants Regional Market: Segment Dashboard
4.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
4.4 Market Size, Forecasts, and Trend Analysis, 2015 to 2026
4.4.1 North America
4.4.1.1 North America contraceptive implants market, 2015 - 2026 (USD Million)
4.4.1.2 U.S.
4.4.1.2.1 Regulatory and reimbursement scenario
4.4.1.2.2 U.S. contraceptive implants market, 2015 - 2026 (USD Million)
4.4.1.3 Canada
4.4.1.3.1 Regulatory and reimbursement scenario
4.4.1.3.2 Canada contraceptive implants market, 2015 - 2026 (USD Million)
4.4.2 Europe
4.4.2.1 Europe contraceptive implants market, 2015 - 2026 (USD Million)
4.4.2.2 Germany
4.4.2.2.1 Regulatory and reimbursement scenario
4.4.2.2.2 Germany contraceptive implants market, 2015 - 2026 (USD Million)
4.4.2.3 U.K.
4.4.2.3.1 Regulatory and reimbursement scenario
4.4.2.3.2 U.K. contraceptive implants market, 2015 - 2026 (USD Million)
4.4.2.4 France
4.4.2.4.1 Regulatory and reimbursement scenario
4.4.2.4.2 France contraceptive implants market, 2015 - 2026 (USD Million)
4.4.2.5 Italy
4.4.2.5.1 Regulatory and reimbursement scenario
4.4.2.5.2 Italy contraceptive implants market, 2015 - 2026 (USD Million)
4.4.2.6 Spain
4.4.2.6.1 Regulatory and reimbursement scenario
4.4.2.6.2 Spain contraceptive implants market, 2015 - 2026 (USD Million)
4.4.3 Asia Pacific
4.4.3.1 Asia Pacific contraceptive implants market, 2015 - 2026 (USD Million)
4.4.3.2 Japan
4.4.3.2.1 Regulatory and reimbursement scenario
4.4.3.2.2 Japan contraceptive implants market, 2015 - 2026 (USD Million)
4.4.3.3 China
4.4.3.3.1 Regulatory and reimbursement scenario
4.4.3.3.2 China contraceptive implants market, 2015 - 2026 (USD Million)
4.4.3.4 India
4.4.3.4.1 Regulatory and reimbursement scenario
4.4.3.4.2 India contraceptive implants market, 2015 - 2026 (USD Million)
4.4.4 Latin America
4.4.4.1 Latin America contraceptive implants market, 2015 - 2026 (USD Million)
4.4.4.2 Brazil
4.4.4.2.1 Regulatory and reimbursement scenario
4.4.4.2.2 Brazil contraceptive implants market, 2015 - 2026 (USD Million)
4.4.4.3 Mexico
4.4.4.3.1 Regulatory and reimbursement scenario
4.4.4.3.2 Mexico contraceptive implants market, 2015 - 2026 (USD Million)
4.4.5 Middle East and Africa
4.4.5.1 MEA contraceptive implants market, 2015 - 2026 (USD Million)
4.4.5.2 South Africa
4.4.5.2.1 Regulatory and reimbursement scenario
4.4.5.2.2 South Africa contraceptive implants market, 2015 - 2026 (USD Million)
CHAPTER 5 COMPETITIVE ANALYSIS
5.1 Recent developments & impact analysis, by key market participants
5.2 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
5.2.1 Strategy Mapping
5.3 Public and Private Companies
5.3.1 Company market position analysis (Overall market presence, geographic presence, product portfolio, and Strategic Initiatives)
5.4 Supplier/Distributor Shipment Data
5.4.1 Top 10 FP2020 Countries in terms of contraceptives supplier-shipment values, 2017
5.5 Company Profiles
5.5.1 Bayer AG
5.5.1.1 Company overview
5.5.1.2 Financial performance
5.5.1.3 Product benchmarking
5.5.1.4 Strategic initiatives
5.5.1.5 SWOT analysis
5.5.2 Merck & Co., Inc.
5.5.2.1 Company overview
5.5.2.2 Financial performance
5.5.2.3 Product benchmarking
5.5.2.4 Strategic initiative
5.5.2.5 SWOT analysis
5.5.3 Shanghai Dahua Pharmaceutical Co., Ltd.
5.5.3.1 Company overview
5.5.3.2 Product benchmarking
5.5.3.3 Strategic initiatives
5.5.3.4 SWOT analysis
CHAPTER 6 KOL COMMENTARY
6.1 KoL Commentary
1.1 Market Segmentation & Scope
1.1.1 Regional Scope
1.1.2 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.2 Variable analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective -
1.10.2 Objective -
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Region
2.3 Competitive Insights
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage outlook
3.1.1 Parent market outlook
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Rise in the number of initiatives to promote contraceptive methods
3.3.1.2 Increasing number of unwanted pregnancies
3.3.2 Market restraint analysis
3.3.2.1 Rapidly aging population and rising prevalence of infertility
3.3.2.2 Lack of awareness and adverse effects of contraceptive implants
3.4 Business Environment Analysis Tools
3.4.1 Porter’s five forces analysis
3.4.2 PESTEL analysis
3.5 Major Deals & Strategic Alliances Analysis
3.6 Pipeline Analysis
CHAPTER 4 CONTRACEPTIVE IMPLANTS MARKET: REGIONAL ANALYSIS
4.1 Contraceptive Implants Regional Market Share Analysis, 2018 & 2026
4.2 Contraceptive Implants Regional Market: Segment Dashboard
4.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
4.4 Market Size, Forecasts, and Trend Analysis, 2015 to 2026
4.4.1 North America
4.4.1.1 North America contraceptive implants market, 2015 - 2026 (USD Million)
4.4.1.2 U.S.
4.4.1.2.1 Regulatory and reimbursement scenario
4.4.1.2.2 U.S. contraceptive implants market, 2015 - 2026 (USD Million)
4.4.1.3 Canada
4.4.1.3.1 Regulatory and reimbursement scenario
4.4.1.3.2 Canada contraceptive implants market, 2015 - 2026 (USD Million)
4.4.2 Europe
4.4.2.1 Europe contraceptive implants market, 2015 - 2026 (USD Million)
4.4.2.2 Germany
4.4.2.2.1 Regulatory and reimbursement scenario
4.4.2.2.2 Germany contraceptive implants market, 2015 - 2026 (USD Million)
4.4.2.3 U.K.
4.4.2.3.1 Regulatory and reimbursement scenario
4.4.2.3.2 U.K. contraceptive implants market, 2015 - 2026 (USD Million)
4.4.2.4 France
4.4.2.4.1 Regulatory and reimbursement scenario
4.4.2.4.2 France contraceptive implants market, 2015 - 2026 (USD Million)
4.4.2.5 Italy
4.4.2.5.1 Regulatory and reimbursement scenario
4.4.2.5.2 Italy contraceptive implants market, 2015 - 2026 (USD Million)
4.4.2.6 Spain
4.4.2.6.1 Regulatory and reimbursement scenario
4.4.2.6.2 Spain contraceptive implants market, 2015 - 2026 (USD Million)
4.4.3 Asia Pacific
4.4.3.1 Asia Pacific contraceptive implants market, 2015 - 2026 (USD Million)
4.4.3.2 Japan
4.4.3.2.1 Regulatory and reimbursement scenario
4.4.3.2.2 Japan contraceptive implants market, 2015 - 2026 (USD Million)
4.4.3.3 China
4.4.3.3.1 Regulatory and reimbursement scenario
4.4.3.3.2 China contraceptive implants market, 2015 - 2026 (USD Million)
4.4.3.4 India
4.4.3.4.1 Regulatory and reimbursement scenario
4.4.3.4.2 India contraceptive implants market, 2015 - 2026 (USD Million)
4.4.4 Latin America
4.4.4.1 Latin America contraceptive implants market, 2015 - 2026 (USD Million)
4.4.4.2 Brazil
4.4.4.2.1 Regulatory and reimbursement scenario
4.4.4.2.2 Brazil contraceptive implants market, 2015 - 2026 (USD Million)
4.4.4.3 Mexico
4.4.4.3.1 Regulatory and reimbursement scenario
4.4.4.3.2 Mexico contraceptive implants market, 2015 - 2026 (USD Million)
4.4.5 Middle East and Africa
4.4.5.1 MEA contraceptive implants market, 2015 - 2026 (USD Million)
4.4.5.2 South Africa
4.4.5.2.1 Regulatory and reimbursement scenario
4.4.5.2.2 South Africa contraceptive implants market, 2015 - 2026 (USD Million)
CHAPTER 5 COMPETITIVE ANALYSIS
5.1 Recent developments & impact analysis, by key market participants
5.2 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
5.2.1 Strategy Mapping
5.3 Public and Private Companies
5.3.1 Company market position analysis (Overall market presence, geographic presence, product portfolio, and Strategic Initiatives)
5.4 Supplier/Distributor Shipment Data
5.4.1 Top 10 FP2020 Countries in terms of contraceptives supplier-shipment values, 2017
5.5 Company Profiles
5.5.1 Bayer AG
5.5.1.1 Company overview
5.5.1.2 Financial performance
5.5.1.3 Product benchmarking
5.5.1.4 Strategic initiatives
5.5.1.5 SWOT analysis
5.5.2 Merck & Co., Inc.
5.5.2.1 Company overview
5.5.2.2 Financial performance
5.5.2.3 Product benchmarking
5.5.2.4 Strategic initiative
5.5.2.5 SWOT analysis
5.5.3 Shanghai Dahua Pharmaceutical Co., Ltd.
5.5.3.1 Company overview
5.5.3.2 Product benchmarking
5.5.3.3 Strategic initiatives
5.5.3.4 SWOT analysis
CHAPTER 6 KOL COMMENTARY
6.1 KoL Commentary
LIST OF TABLES
TABLE 1 List of secondary sources
TABLE 2 List of abbreviation
TABLE 3 Characteristics of different subdermal contraceptive implants
TABLE 4 Supply chain contraceptive shipment details
TABLE 1 List of secondary sources
TABLE 2 List of abbreviation
TABLE 3 Characteristics of different subdermal contraceptive implants
TABLE 4 Supply chain contraceptive shipment details
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market outlook
Fig. 9 Contraceptive implants market segmentation
Fig. 10 Market trends & outlook
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Porter's five forces analysis
Fig. 14 PESTEL analysis
Fig. 15 Subdermal contraceptive implants regional market share analysis, 2018 & 2026
Fig. 16 Subdermal contraceptive implants regional market: Segment dashboard
Fig. 17 Regional marketplace: Key takeaways
Fig. 18 North America subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 19 U.S. subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 20 Canada subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 21 Europe subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 22 Germany subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 23 U.K. subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 24 France subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 25 Italy subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 26 Spain subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 27 Asia Pacific subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 28 China subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 29 India subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 30 Japan subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 31 Latin America subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 32 Brazil subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 33 Mexico subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 34 MEA subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 35 South Africa subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 36 Recent developments
Fig. 37 Strategy framework
Fig. 38 Strategy mapping
Fig. 39 Company market position analysis ( Market presence, geographical presence, product portfolio, & strategic initiatives)
Fig. 40 Top 10 FP2020 countries in terms of contraceptives supplier-shipment values, 2017
Fig. 41 KoL commentary
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market outlook
Fig. 9 Contraceptive implants market segmentation
Fig. 10 Market trends & outlook
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Porter's five forces analysis
Fig. 14 PESTEL analysis
Fig. 15 Subdermal contraceptive implants regional market share analysis, 2018 & 2026
Fig. 16 Subdermal contraceptive implants regional market: Segment dashboard
Fig. 17 Regional marketplace: Key takeaways
Fig. 18 North America subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 19 U.S. subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 20 Canada subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 21 Europe subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 22 Germany subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 23 U.K. subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 24 France subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 25 Italy subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 26 Spain subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 27 Asia Pacific subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 28 China subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 29 India subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 30 Japan subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 31 Latin America subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 32 Brazil subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 33 Mexico subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 34 MEA subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 35 South Africa subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 36 Recent developments
Fig. 37 Strategy framework
Fig. 38 Strategy mapping
Fig. 39 Company market position analysis ( Market presence, geographical presence, product portfolio, & strategic initiatives)
Fig. 40 Top 10 FP2020 countries in terms of contraceptives supplier-shipment values, 2017
Fig. 41 KoL commentary
